Importer of Controlled Substances Application: R & D Systems, Inc., 35546-35547 [2017-16064]

Download as PDF 35546 Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices personal identifying information in your comment, you should be aware that your entire comment, including your personal identifying information, may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. Authority: The authorities for this action are the Surface Mining Control and Reclamation Act of 1977, as amended (30 U.S.C. 1201 et seq.), and the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). Dated: June 15, 2017. John A. Trelease, Acting Chief, Division of Regulatory Support. [FR Doc. 2017–16044 Filed 7–28–17; 8:45 am] BILLING CODE 4310–05–P DEPARTMENT OF JUSTICE filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Chrysler Group, LLC, Auburn Hills, MI, and Mercedes-Benz Research & Development North America, Inc., Sunnyvale, CA, have withdrawn as a parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and V2I Consortium intends to file additional written notifications disclosing all changes in membership. On December 3, 2014, V2I Consortium filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on December 31, 2014 (79 FR 78908). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. Antitrust Division Notice Pursuant to the National Cooper, Ative Research and Production Act of 1993—Vehicle To Infrastructure Consortium [FR Doc. 2017–16050 Filed 7–28–17; 8:45 am] BILLING CODE P Notice is hereby given that, on June 29, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Vehicle to Infrastructure Consortium (‘‘V2I Consortium’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Isosciences, LLC ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before September 29, 2017. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on May 17, 2017, Isosciences, LLC, 1017 West 9th Avenue, Building 10, Suite B, King of Prussia, Pennsylvania 19406 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance Drug code sradovich on DSKBCFCHB2PROD with NOTICES Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. Lysergic acid diethylamide .............................................................................................................................................. 3,4-Methylenedioxyamphetamine .................................................................................................................................... 3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... Amphetamine ................................................................................................................................................................... Methamphetamine ........................................................................................................................................................... Codeine ........................................................................................................................................................................... Morphine .......................................................................................................................................................................... The company plans to manufacture small quantities of the listed controlled substances to make reference standards which will be distributed to their customers. Dated: July 24, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–16060 Filed 7–28–17; 8:45 am] BILLING CODE 4410–09–P VerDate Sep<11>2014 17:38 Jul 28, 2017 Jkt 241001 DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: R & D Systems, Inc. ACTION: Notice of application. PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 I I I I I II II II II comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before August 30, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before August 30, 2017. Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 ADDRESSES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written DATES: 1235 1237 7315 7400 7404 1100 1105 9050 9300 Schedule E:\FR\FM\31JYN1.SGM 31JYN1 35547 Federal Register / Vol. 82, No. 145 / Monday, July 31, 2017 / Notices Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or SUPPLEMENTARY INFORMATION: revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on March 7, 2017, R & D Systems, Inc., BioTechne, 614 McKinley Place NE., Minneapolis, Minnesota 55413 applied to be registered as an importer of the following basic classes of controlled substances: Controlled substance Drug code Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................ Marihuana ........................................................................................................................................................................ Tetrahydrocannabinols .................................................................................................................................................... 4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 3,4-Methylenedioxymethamphetamine ............................................................................................................................ Dimethyltryptamine .......................................................................................................................................................... Psilocyn ........................................................................................................................................................................... Pentobarbital .................................................................................................................................................................... Phencyclidine ................................................................................................................................................................... Cocaine ............................................................................................................................................................................ The company plans to import bulk active pharmaceutical controlled substances for distribution to its customers for analytical purposes. In reference to drug codes 7360 and 7370, the company plans to import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No other activity for these drug codes is authorized for this registration. Dated: July 24, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–16064 Filed 7–28–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Sigma-Aldrich International GMBH ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and sradovich on DSKBCFCHB2PROD with NOTICES DATES: applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before August 30, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before August 30, 2017. Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. Comments and requests for hearings on applications to import narcotic raw ADDRESSES: Drug code Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... N-Ethylamphetamine ....................................................................................................................................................... Aminorex .......................................................................................................................................................................... Gamma Hydroxybutyric Acid ........................................................................................................................................... 17:38 Jul 28, 2017 Jkt 241001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 I I I I I I I I I II II II material are not appropriate. 72 FR 3417, (January 25, 2007). SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix of subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on January 19, 2016, Sigma-Aldrich International GMBH, Sigma Aldrich Co. LLC, 3500 Dekalb Street, Saint Louis, Missouri 63118 applied to be registered as an importer of the following basic classes of controlled substances: Controlled substance VerDate Sep<11>2014 1248 7118 7297 7360 7370 7391 7405 7435 7438 2270 7471 9041 Schedule E:\FR\FM\31JYN1.SGM 31JYN1 1235 1237 1248 1475 1585 2010 Schedule I I I I I I

Agencies

[Federal Register Volume 82, Number 145 (Monday, July 31, 2017)]
[Notices]
[Pages 35546-35547]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16064]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: R & D Systems, 
Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.34(a) on or before August 30, 2017. Such persons may also file a 
written request for a hearing on the application pursuant to 21 CFR 
1301.43 on or before August 30, 2017.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701

[[Page 35547]]

Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on March 
7, 2017, R & D Systems, Inc., Bio-Techne, 614 McKinley Place NE., 
Minneapolis, Minnesota 55413 applied to be registered as an importer of 
the following basic classes of controlled substances:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Mephedrone (4-Methyl-N-                        1248  I
 methylcathinone).
JWH-018 (also known as AM678) (1-              7118  I
 Pentyl-3-(1-naphthoyl)indole).
CP-47,497 (5-(1,1-Dimethylheptyl)-2-           7297  I
 [(1R,3S)-3-hydroxycyclohexyl-
 phenol).
Marihuana..........................            7360  I
Tetrahydrocannabinols..............            7370  I
4-Bromo-2,5-dimethoxyamphetamine...            7391  I
3,4-Methylenedioxymethamphetamine..            7405  I
Dimethyltryptamine.................            7435  I
Psilocyn...........................            7438  I
Pentobarbital......................            2270  II
Phencyclidine......................            7471  II
Cocaine............................            9041  II
------------------------------------------------------------------------

    The company plans to import bulk active pharmaceutical controlled 
substances for distribution to its customers for analytical purposes.
    In reference to drug codes 7360 and 7370, the company plans to 
import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No 
other activity for these drug codes is authorized for this 
registration.

    Dated: July 24, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-16064 Filed 7-28-17; 8:45 am]
 BILLING CODE 4410-09-P